alexa Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies

Immune thrombocytopenia (ITP) is one of the rare causes of childhood thrombocytopenia, defined as peripheral isolated thrombocytopenia under 100 G/L. The incidence of newly diagnosed ITP is 2.2 to 5.3/105 children/year. In children, ITP is usually an acute self-limiting disease. In contrast with adult patients, a chronic course of more than 12 months only occurs in 20% of cases and only a small percentage of these cases may require second-lines therapies.

 

Citation: Aladjidi N, Santiago R, Pondarré C, Lambilliotte A, Leverger G, et al. (2012) Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience. J Blood Disorders Transf S3:003. doi: 10.4172/2155-9864.S3-003

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger